Table 2.
Surgical results (N=14).
| Variable | Values | |||
| Surgical procedure, n (%) | ||||
|
|
VATSa with wedge resection | 5 (35.7) | ||
|
|
VATS with segmentectomy | 9 (64.3) | ||
| Operation time (min), mean (SD) | 95.6 (42.1) | |||
| Navigation time (min), mean (SD) | 38.6 (19.5) | |||
| Tumor localization techniqueb, n (%) | ||||
|
|
Intraoperative localization | |||
|
|
|
LungVision system | 14 (100) | |
|
|
Initial localization method (combined) | |||
|
|
|
CTc-guided technique | 11 (78.6) | |
|
|
|
Broncus Medical Archimedes system | 3 (21.4) | |
| Dye in appearance (LungVision system), n (%) | 11 (78.6) | |||
| Pathological diagnosis, n (%) | ||||
|
|
Malignancy | 10 (71.4) | ||
|
|
Benign | 4 (28.6) | ||
|
|
Adenocarcinoma | 5 (35.7) | ||
|
|
Minimally invasive adenocarcinoma | 3 (21.4) | ||
|
|
Adenocarcinoma in situ | 1 (7.1) | ||
|
|
Metastatic adenocarcinoma | 1 (7.1) | ||
|
|
Chondroid hamartoma | 1 (7.1) | ||
|
|
Cryptococcosis | 1 (7.1) | ||
|
|
Chronic inflammation | 2 (14.3) | ||
aVATS: video-assisted thoracoscopic surgery.
bAll patients received dual localization: initial localization (computed tomography guided or via the Archimedes system) followed by intraoperative localization using the LungVision system.
cCT: computed tomography.